This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsu, L.-C. Articles by White, R. L. Search for Related Content PubMed PubMed Citation Articles by Hsu, L.-C. Articles by White, R. L.

Identification of a -Tubulin-binding Domain in BRCA1¹

Department of Oncological Sciences, University of Utah, Salt Lake City, Utah 84112

We previously reported (L-C. Hsu and R. L. White, Proc. Natl. Acad. Sci. USA, 95: 12983–12988, 1998) that hypophosphorylated BRCA1 is associated with mitotic centrosomes in vivo, perhaps through its interaction with -tubulin. In vitro evidence presented here indicates that full-length BRCA1 protein generated by in vitro translation interacts with -tubulin. A specific domain of BRCA1 protein, BRCA1 fragment no. 3 (BF3; amino acids 504–803), is both necessary and sufficient to bind -tubulin. BF3 and -tubulin coimmunoprecipitated when coexpressed in cells. In addition, expression of BF3 interfered with the interaction between BRCA1 and -tubulin. Stable transformants of COS-7 cells that overexpressed BF3 showed a reduced growth rate partly because of increased apoptosis. Furthermore, overexpression of BF3 in COS-7 cells results in the accumulation of mitotic cells with multiple centrosomes and abnormal spindles. Okadaic acid, an inhibitor of protein phosphatases types 1 and 2A, induces hyperphosphorylation of BRCA1, a reduction of both BRCA1 and -tubulin associated with mitotic centrosomes, and an accumulation of abnormal spindle formation. Thus, attenuating the interaction between BRCA1 and -tubulin, and their association with mitotic centrosomes, may induce an increase of aneuploid cell population and contribute to tumorigenesis.

This article has been cited by other articles:

				S. Jin, H. Gao, L. Mazzacurati, Y. Wang, W. Fan, Q. Chen, W. Yu, M. Wang, X. Zhu, C. Zhang, et al. BRCA1 Interaction of Centrosomal Protein Nlp Is Required for Successful Mitotic Progression J. Biol. Chem., August 21, 2009; 284(34): 22970 - 22977. [Abstract] [Full Text] [PDF]

				S. Ryser, E. Dizin, C. E. Jefford, B. Delaval, S. Gagos, A. Christodoulidou, K.-H. Krause, D. Birnbaum, and I. Irminger-Finger Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1{beta} Scaffolds Aurora B and BRCA2 Cancer Res., February 1, 2009; 69(3): 1125 - 1134. [Abstract] [Full Text] [PDF]

				B. Xiong, S. Li, J.-S. Ai, S. Yin, Y.-C. OuYang, S.-C. Sun, D.-Y. Chen, and Q.-Y. Sun BRCA1 Is Required for Meiotic Spindle Assembly and Spindle Assembly Checkpoint Activation in Mouse Oocytes Biol Reprod, October 1, 2008; 79(4): 718 - 726. [Abstract] [Full Text] [PDF]

				C. A. Maxwell, J. McCarthy, and E. Turley Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci., April 1, 2008; 121(7): 925 - 932. [Abstract] [Full Text] [PDF]

				S. Sankaran, D. E. Crone, R. E. Palazzo, and J. D. Parvin Aurora-A Kinase Regulates Breast Cancer Associated Gene 1 Inhibition of Centrosome-Dependent Microtubule Nucleation Cancer Res., December 1, 2007; 67(23): 11186 - 11194. [Abstract] [Full Text] [PDF]

				S. L. Barrett and D. F. Albertini Allocation of Gamma-Tubulin Between Oocyte Cortex and Meiotic Spindle Influences Asymmetric Cytokinesis in the Mouse Oocyte Biol Reprod, June 1, 2007; 76(6): 949 - 957. [Abstract] [Full Text] [PDF]

				S. S. Kim, L. Cao, S.-C. Lim, C. Li, R.-H. Wang, X. Xu, R. Bachelier, and C.-X. Deng Hyperplasia and Spontaneous Tumor Development in the Gynecologic System in Mice Lacking the BRCA1-{Delta}11 Isoform. Mol. Cell. Biol., September 1, 2006; 26(18): 6983 - 6992. [Abstract] [Full Text] [PDF]

				M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400. [Abstract] [Full Text] [PDF]

				S. Sankaran, L. M. Starita, A. M. Simons, and J. D. Parvin Identification of Domains of BRCA1 Critical for the Ubiquitin-Dependent Inhibition of Centrosome Function. Cancer Res., April 15, 2006; 66(8): 4100 - 4107. [Abstract] [Full Text] [PDF]

				A. R. Lindh, S. Rafii, N. Schultz, A. Cox, and T. Helleday Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility Hum. Mol. Genet., April 1, 2006; 15(7): 1217 - 1224. [Abstract] [Full Text] [PDF]

				P K Lovelock, S Healey, W Au, E Y M Sum, A Tesoriero, E M Wong, S Hinson, R Brinkworth, A Bekessy, O Diez, et al. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants J. Med. Genet., January 1, 2006; 43(1): 74 - 83. [Abstract] [Full Text] [PDF]

				S. Sankaran, L. M. Starita, A. C. Groen, M. J. Ko, and J. D. Parvin Centrosomal Microtubule Nucleation Activity Is Inhibited by BRCA1-Dependent Ubiquitination Mol. Cell. Biol., October 1, 2005; 25(19): 8656 - 8668. [Abstract] [Full Text] [PDF]

				A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679. [Abstract] [Full Text] [PDF]

				F. Al-Mulla, M. Abdulrahman, G. Varadharaj, N. Akhter, and J. T. Anim BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry J. Histochem. Cytochem., May 1, 2005; 53(5): 621 - 629. [Abstract] [Full Text] [PDF]

				R. D. Kennedy, J. E. Quinn, P. B. Mullan, P. G. Johnston, and D. P. Harkin The Role of BRCA1 in the Cellular Response to Chemotherapy J Natl Cancer Inst, November 17, 2004; 96(22): 1659 - 1668. [Abstract] [Full Text] [PDF]

				L. M. Starita, Y. Machida, S. Sankaran, J. E. Elias, K. Griffin, B. P. Schlegel, S. P. Gygi, and J. D. Parvin BRCA1-Dependent Ubiquitination of {gamma}-Tubulin Regulates Centrosome Number Mol. Cell. Biol., October 1, 2004; 24(19): 8457 - 8466. [Abstract] [Full Text] [PDF]

				A. D. Choudhury, H. Xu, and R. Baer Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918. [Abstract] [Full Text] [PDF]

				X. Wang, R.-H. Wang, W. Li, X. Xu, M. C. Hollander, A. J. Fornace Jr., and C.-X. Deng Genetic Interactions between Brca1 and Gadd45a in Centrosome Duplication, Genetic Stability, and Neural Tube Closure J. Biol. Chem., July 9, 2004; 279(28): 29606 - 29614. [Abstract] [Full Text] [PDF]

				M. D Vos, A. Martinez, C. Elam, A. Dallol, B. J Taylor, F. Latif, and G. J Clark A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability Cancer Res., June 15, 2004; 64(12): 4244 - 4250. [Abstract] [Full Text] [PDF]

				M. Garriga-Canut and S. H. Orkin Transforming Acidic Coiled-coil Protein 3 (TACC3) Controls Friend of GATA-1 (FOG-1) Subcellular Localization and Regulates the Association between GATA-1 and FOG-1 during Hematopoiesis J. Biol. Chem., May 28, 2004; 279(22): 23597 - 23605. [Abstract] [Full Text] [PDF]

				M. Ouchi, N. Fujiuchi, K. Sasai, H. Katayama, Y. A. Minamishima, P. P. Ongusaha, C. Deng, S. Sen, S. W. Lee, and T. Ouchi BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition J. Biol. Chem., May 7, 2004; 279(19): 19643 - 19648. [Abstract] [Full Text] [PDF]

				C.-X. Deng and R.-H. Wang Roles of BRCA1 in DNA damage repair: a link between development and cancer Hum. Mol. Genet., April 2, 2003; 12(90001): R113 - 123. [Abstract] [Full Text] [PDF]

				S. Okada and T. Ouchi Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization J. Biol. Chem., January 10, 2003; 278(3): 2015 - 2020. [Abstract] [Full Text] [PDF]

				Y. Liu, D. M. Virshup, R. L. White, and L.-C. Hsu Regulation of BRCA1 Phosphorylation by Interaction with Protein Phosphatase 1{alpha} Cancer Res., November 15, 2002; 62(22): 6357 - 6361. [Abstract] [Full Text] [PDF]